Duration of Doxycycline Treatment in MEM Patients

University Medical Centre Ljubljana

Status: Enrolling

Conditions: Erythema Chronicum Migrans

Treatments: Drug: Doxycycline 100 milligram Oral Tablet bid, 14 days; Drug: Doxycycline 100 milligram Oral Tablet bid, 7 days; Drug: Controls without a history of lyme disease.

Study type: Interventional

Funder types: Other

Identifiers

NCT03337932

MEM-Doxy

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• multiple erythema migrans

Exclusion criteria

• pregnancy or lactation
• immunocompromised
• serious adverse event to doxycycline
• taking antibiotic with antiborrelial activity within 10 days
• extracutaneous manifestations of lyme borreliosis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 3 patient groups, including a placebo group

MEM-7 days doxycycline

Active Comparator group

Treatment:

Drug: Doxycycline 100 milligram Oral Tablet bid, 7 days

MEM-14 days doxycycline

Active Comparator group

Treatment:

Drug: Doxycycline 100 milligram Oral Tablet bid, 14 days

Controls

Placebo Comparator group

Treatment:

Drug: Controls without a history of lyme disease.